Surgical Quality Improvement

Breast Reconstruction

Breast Reconstruction ACS NSQIP Outcomes

January 1, 2024– December 31, 2024

The American College of Surgeons National Surgical Quality Improvement Program (ACS NSQIP®) objectively measures and reports risk-adjusted surgical outcomes based on a defined sampling and abstraction methodology. These outcomes data reflect Cleveland Clinic’s overall breast reconstruction surgery ACS NSQIP performance benchmarked against 342 participating sites.

Breast Reconstruction (342 Sites)NObservedExpected
30 Day Morbidity3998.02%5.92%
Pneumonia3990.50%0.13%
Deep Vein Thrombosis (DVT) / Pulmonary Embolus3991.00%0.46%
Renal Failure3990.00%0.05%
Urinary Tract Infection (UTI)3990.50%0.18%
Surgical Site Infection (SSI)3996.27%4.73%
Sepsis3990.00%0.21%
Unplanned Reoperation3998.02%6.01%
Unplanned Readmissionᵃ3996.27%3.73%

American College of Surgeons National Surgical Quality Improvement Program, 2025.
ACS NSQIP® Semiannual Report July, 2025, Chicago: American College of Surgeons.

ᵃIdentified as a statistical outlier (higher than expected) by the ACS NSQIP hierarchical model.